$HUGE just wait until the HUGE chasers realize $HGEN is already in phase 3 with their Cytokine storm drug lenzilumab. $HGEN massive funding from $JPM yesterday and relisting to the Nasdaq. Trading at $2.50 with Phase 3 news pending.... https://t.co/2IhycycbgY